AXA XL uses two forms of cookies on this site:

  1. to enable the site to operate and retain any preferences you set
  2. for analytics to make the site more relevant and easy to use

These cookies do not collect personal information. For more information about our cookie usage, please click here. To comply with EU privacy laws you must consent to our use of cookies.

By using this site, you agree that we can place these types of cookies on your device. If you choose to change your cookie settings you will be presented with this message the next time you visit.

Fast Fast Forward

On Our Radar:Trans Fat

On Our Radar_Emerging Risks

In June 2015, the US Food and Drug Administration (US FDA) ruled to ban trans fat from hundreds of foods.  Food manufacturers, restaurants and others have until June 2018 to comply.  While many have already been working to phase out trans fat from their products, others don’t think it will be that easy and are petitioning for some continued use. 

The ban, as well as a business’ continued use of trans fat in products, could pose potential risks and XL Catlin’s Enterprise Risk Management and Casualty Risk Engineering teams continue to monitor the potential, watching for possible litigation against food/beverage manufacturers, distributors, suppliers and advertisers, as well as potential product recall actions as a result of the recent FDA decision.  Trans fat continues to be an emerging risk that XL Catlin is watching. 


© 2018 AXA SA or its affiliates
AXA XL is the P&C and specialty risk division of AXA.